Robert Davis - Chief Executive Officer @ Merck

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

82,256

Primary Job Title Chief Executive Officer
Primary Organization
Merck

Location Rahway, New Jersey, United States
Regions Greater New York Area, East Coast, Northeastern US
Gender Male
Also Known As Rob Davis

Investor Type
obfuscated
obfuscation

LinkedIn View on LinkedIn

Robert M. Davis is based out of Rahway, New Jersey, and is the Chief Executive Officer and Chairman of the Board at Merck. Robert previously at Baxter Healthcare as a CVP and President of Medical Products. Robert M. Davis attended Miami University. .

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Children's Inn At NIH	Merck Foundation	Yes	Grant - Children's Inn At NIH	obfuscated obfuscation

Jobs

Number of Current Jobs

Number of Past Jobs

Robert Davis

is the

Chief Executive Officer

Merck

. Additionally,

Robert Davis

has had

past jobs including

Chief Executive Officer and President

Merck

Merck Chief Executive OfficerDec 1, 2022

Organization Name	Title At Company	Start Date	End Date
Merck	Chief Executive Officer and President	Jul 1, 2021	Dec 2022
Baxter International	CVP and President of Medical Products	May 2010	Apr 2014

Board and Advisor Roles

Number of Current Board & Advisor Roles

Robert Davis

is the

Chairman of the Board

Merck

Merck Chairman of the BoardDec 1, 2022

Related Hubs

Hub Name	CB Rank (Hub)
New Jersey Investors	23,728
United States Pharmaceutical Public Companies	54,081
Medical Companies With More Than $50M in Revenue	4,573
Biotechnology Public Companies With More Than 50 Employees	20,183
Biotechnology Companies With More Than $1M in Revenue (Top 10K)	2,636
Greater New York Area Companies With More Than 100 Employees (Top 10K)	1,975
Greater New York Area Companies With More Than $100M in Revenue	7,528
East Coast Investors with Funds Raised in 2015	59,722
Medical Public Companies With More Than $50M in Revenue	30,426
Pharmaceutical Public Companies With More Than 50 Employees	21,212